2019 CAR T Symposium

The Present Landscape and Future Considerations

The Mayflower Hotel, Palm Court Ballroom
Washington, DC
Monday, October 21
2:00-5:00 pm ET
The 2019 CAR T Symposium, in collaboration with the Society for Immunotherapy of Cancer (SITC), aims to identify the challenges of delivering CAR T-cell therapy, including patient access, delivery and barriers to care, and to discuss potential solutions. The meeting will bring together academic and community clinical physicians, clinical administrators, clinical directors for cellular and transplantation programs, nursing managers, clinical research directors, patient advocates, government employees, and industry stakeholders. As part of the program’s learning objectives, attendees will discuss:
  • Financial and technical challenges of manufacturing and administering CAR T therapy at academic cancer centers and innovative solutions to address barriers to care

  • Barriers associated with navigating the health care system and steps cancer centers can take to provide quality care while minimizing complications for patients

  • Challenges and opportunities for collaboration between academia, government, industry, and the private sector to leverage the benefits of CAR T therapy by improving the safety and efficacy for patients while reducing manufacturing costs that will ultimately reduce cost of care

  • Opportunities for advancing cellular therapy clinical research at academic cancer centers

The 2019 CAR T Symposium is free to all attendees. Registration is required, and space is limited. Priority will be given to AACI and SITC members. Industry partners interested in supporting this meeting may contact AACI Director of Development, Kate Burroughs, at 412-647-3844. 

Please note: The CAR T Symposium is being held in conjunction with the AACI/CCAF Annual Meeting, October 20-22 at The Mayflower Hotel. Those who wish to attend the AACI/CCAF Annual Meeting in addition to the CAR T symposium must register for the annual meeting.

Meeting Program

Program is subject to change. 


2:00 - 2:10 pm


Joseph McGuirk, DO
The University of Kansas Cancer Center

2:10 - 2:30 pm

Keynote: The Present Landscape and Future Considerations of CAR T

2:30 - 3:30 pm

Navigating the Health System to Establish and Administer a CAR T Program

3:30 - 3:45 pm


3:45 - 4:45 pm 

Exploring the Value and Cost-Effectiveness of CAR T-Cell Therapy

4:45 - 5:00 pm


Closing Remarks
Joseph McGuirk, DO
The University of Kansas Cancer Center